itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens (vol 66, 103288, 2021)

被引：0

作者：

Liesenborghs, Laurens ^{[1
,2
]}

Spriet, Isabel ^{[3
,4
]}

Jochmans, Dirk ^{[1
]}

Belmans, Ann ^{[5
,6
]}

Gyselinck, Iwein ^{[7
,8
]}

Teuwen, Laure-Anne ^{[9
]}

ter Horst, Sebastiaan ^{[1
]}

Dreesen, Erwin ^{[10
]}

Geukens, Tatjana ^{[11
]}

Engelen, Matthias M. ^{[12
,13
]}

Landeloos, Ewout ^{[14
]}

Geldhof, Vincent ^{[9
]}

Ceunen, Helga ^{[15
,16
]}

Debaveye, Barbara ^{[12
,13
]}

Vandenberk, Bert ^{[12
,13
]}

Van der Linden, Lorenz ^{[3
,4
]}

Jacobs, Sofie ^{[1
]}

Langendries, Lana ^{[1
]}

Boudewijns, Robbert ^{[1
]}

Do, Thuc Nguyen Dan ^{[1
]}

Chiu, Winston ^{[1
]}

Wang, Xinyu ^{[1
]}

Zhang, Xin ^{[1
]}

Weynand, Birgit ^{[17
]}

Vanassche, Thomas ^{[12
,13
]}

Devos, Timothy ^{[18
,19
]}

Meyfroidt, Geert ^{[13
,20
]}

Janssens, Wim ^{[7
,8
]}

Vos, Robin ^{[7
,8
]}

Vermeersch, Pieter ^{[21
,22
]}

Wauters, Joost ^{[16
,23
]}

Verbeke, Geert ^{[5
,6
]}

De Munter, Paul ^{[15
,16
]}

Kaptein, Suzanne J. F. ^{[1
]}

Rocha-Pereira, Joana ^{[1
]}

Delang, Leen ^{[1
]}

Van Wijngaerden, Eric ^{[15
,16
]}

Neyts, Johan ^{[1
]}

Verhamme, Peter ^{[12
,13
]}

机构：

[1] Katholieke Univ Leuven, Lab Virol & Chemotherapy, Dept Microbiol Immunol & Transplantat, Rega Inst Med Res, Leuven, Belgium

[2] Inst Trop Med, Outbreak Res Team, Dept Clin Sci, Antwerp, Belgium

[3] Katholieke Univ Leuven, Pharm Dept Univ Hosp Leuven, Leuven, Belgium

[4] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium

[5] KU Leuven Univ Leuven, Leuven, Belgium

[6] Univ Hasselt, I BioStat, Leuven, Belgium

[7] Katholieke Univ Leuven, Dept Resp Dis, UZ Leuven, Leuven, Belgium

[8] Katholieke Univ Leuven, CHROMETA, Res Grp BREATHE, Leuven, Belgium

[9] Katholieke Univ Leuven, Lab Angiogenesis & Vasc Metab, Ctr Canc Biol, VIB,Dept Oncol,Leuven Canc Inst, Leuven, Belgium

[10] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy Unit, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium

[11] Katholieke Univ Leuven, Dept Oncol, Lab Translat Breast Canc Res, Leuven, Belgium

[12] UZ, Dept Cardiovasc Sci, Leuven, Belgium

[13] Katholieke Univ Leuven, Leuven, Belgium

[14] VIB KU Leuven, Dept Oncol, Lab Mol Canc Biol, Leuven, Belgium

[15] Katholieke Univ Leuven, Dept Gen Internal Med, UZ Leuven, Leuven, Belgium

[16] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium

[17] Katholieke Univ Leuven, Translat Cell & Tissue Res, Dept Imaging & Pathol, Leuven, Belgium

[18] Katholieke Univ Leuven, Dept Hematol, UZ Leuven, Leuven, Belgium

[19] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Lab Mol Immunol, Rega Inst, Leuven, Belgium

[20] UZ, Dept & Lab Intens Care Med, Leuven, Belgium

[21] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium

[22] Katholieke Univ Leuven, Dept Clin Lab Med, Leuven, Belgium

[23] Katholieke Univ Leuven, Med Intens Care Unit, Leuven, Belgium

来源：

EBIOMEDICINE | 2021年 / 69卷

基金：

欧盟地平线“2020”;

关键词：

D O I：

10.1016/j.ebiom.2021.103454

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：1

共 50 条

[21] Preclinical and randomized phase I studies of plitidepsin in adults with COVID-19
Varona, Jose F.
Landete, Pedro
Lopez-Martin, Jose A.
Estrada, Vicente
Paredes, Roger
Guisado-Vasco, Pablo
Fernandez de Orueta, Lucia
Torralba, Miguel
Fortun, Jesus
Vates, Roberto
Barberan, Jose
Clotet, Bonaventura
Ancochea, Julio
Carnevali, Daniel
Cabello, Noemi
Porras, Lourdes
Gijon, Paloma
Monereo, Alfonso
Abad, Daniel
Zuniga, Sonia
Sola, Isabel
Rodon, Jordi
Vergara-Alert, Julia
Izquierdo-Useros, Nuria
Fudio, Salvador
Jose Pontes, Maria
de Rivas, Beatriz
Giron de Velasco, Patricia
Nieto, Antonio
Gomez, Javier
Aviles, Pablo
Lubomirov, Rubin
Belgrano, Alvaro
Sopesen, Belen
White, Kris M.
Rosales, Romel
Yildiz, Soner
Reuschl, Ann-Kathrin
Thorne, Lucy G.
Jolly, Clare
Towers, Greg J.
Zuliani-Alvarez, Lorena
Bouhaddou, Mehdi
Obernier, Kirsten
McGovern, Briana L.
Rodriguez, M. Luis
Enjuanes, Luis
Fernandez-Sousa, Jose M.
Krogan, Nevan J.
Jimeno, Jose M.
LIFE SCIENCE ALLIANCE, 2022, 5 (04)
[22] Healthcare Personnel Safety During Percutaneous Tracheostomy in Patients With COVID-19: Proof-of-Concept Study
Sood, Rahul N.
Dudiki, Natasha
Alape, Daniel
Maxfiel, Mark W.
JOURNAL OF INTENSIVE CARE MEDICINE, 2021, 36 (05) : 612 - 616
[23] TELEREHABILITATION FOR POST-HOSPITALIZED COVID-19 PATIENTS: A PROOF-OF-CONCEPT STUDY DURING A PANDEMIC
Tanguay, Pamela
Marquis, Nicole
Gaboury, Isabelle
Kairy, Dahlia
Touchette, Matthieu
Tousignant, Michel
Decary, Simon
INTERNATIONAL JOURNAL OF TELEREHABILITATION, 2021, 13 (01):
[24] Association of gut-related metabolites with respiratory symptoms in COVID-19: A proof-of-concept study
Israr, Muhammad Zubair
Ibrahim, Wadah
Salzano, Andrea
Sarmad, Sarir
Wilde, Michael J.
Cordell, Rebecca L.
Greening, Neil J.
Brightling, Christopher E.
Siddiqui, Salman
Suzuki, Toru
NUTRITION, 2022, 96
[25] The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies
Gelenberg, Alan J.
Thase, Michael E.
Meyer, Roger E.
Goodwin, Frederick K.
Katz, Martin M.
Kraemer, Helena Chmura
Potter, William Z.
Shelton, Richard C.
Fava, Maurizio
Khan, Arif
Trivedi, Madhukar H.
Ninan, Philip T.
Mann, John J.
Bergeson, Susan
Endicott, Jean
Kocsis, James H.
Leon, Andrew C.
Manji, Husseini K.
Rosenbaum, Jerrold F.
JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (10) : 1513 - +
[26] Oncology phase II proof-of-concept studies with multiple targets: Randomized controlled trial or single arm?
Jemielita, Thomas
Tse, Archie
Chen, Cong
PHARMACEUTICAL STATISTICS, 2020, 19 (02) : 117 - 125
[27] Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study
Rashidi Springall
Julieta González-Flores
Carlos García-Ávila
Yaneli Juárez-Vicuña
Adrián Hernández-Diazcouder
Ricardo Márquez-Velasco
Sergio Cásares-Alvarado
Fausto Sánchez-Muñoz
Edna Basilio-Gálvez
Mauricio Castillo-Salazar
Martha A. Ballinas-Verdugo
Malinalli Brianza-Padilla
José L. Sánchez-Gloria
Claudia Tavera-Alonso
Julio Sandoval
Héctor González-Pacheco
Luis M. Amezcua-Guerra
Archivum Immunologiae et Therapiae Experimentalis, 2022, 70
[28] Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study
Springall, Rashidi
Gonzalez-Flores, Julieta
Garcia-Avila, Carlos
Juarez-Vicuna, Yaneli
Hernandez-Diazcouder, Adrian
Marquez-Velasco, Ricardo
Casares-Alvarado, Sergio
Sanchez-Munoz, Fausto
Basilio-Galvez, Edna
Castillo-Salazar, Mauricio
Ballinas-Verdugo, Martha A.
Brianza-Padilla, Malinalli
Sanchez-Gloria, Jose L.
Tavera-Alonso, Claudia
Sandoval, Julio
Gonzalez-Pacheco, Hector
Amezcua-Guerra, Luis M.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2022, 70 (01)
[29] REPURPOSING OF GAMMA-HYDROXYBUTYRATE IN DEPRESSION: A RANDOMIZED PLACEBO-CONTROLLED PROOF-OF-CONCEPT CLINICAL TRIAL
Bavato, Francesco
Schnider, Laura K.
Dornbierer, Dario A.
Quednow, Boris B.
Landolt, Hans-Peter
Bosch, Oliver G.
Seifritz, Erich
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i48 - i49
[30] Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study
Sanchez-Conde, Matilde
Vizcarra, Pilar
Perez-Garcia, Jose Manuel
Gion, Maria
Martialay, Maria Pilar
Taboada, Javier
Alonso-Fernandez, Alberto
Sampayo-Cordero, Miguel
Malfettone, Andrea
Tena, Isabel
De la Torre, Sergio
Llombart-Cussac, Antonio
Cortes, Javier
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 123 : 97 - 103

← 1 2 3 4 5 →